ACHILLION PHARMACEUTICALS, INC. $75,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • February 23rd, 2017 • Achillion Pharmaceuticals Inc • Pharmaceutical preparations • New York
Achillion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
